JACOBSON PHARMA

2633
0.9051.63% ( -0.015 )
Delay Closed: Nov 16, 16:08:00

Financials

FY2026 Earnings

Financial report interval: 2025.03.31 - 2026.03.31

Overview: JACOBSON PHARMA(02633) the Revenue is 1.569 B (--%), Beat estimate;the EBIT is 388.65 M (--%), Beat estimate;the EPS is 0.151 (-0.33%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.57B--
1.55B--
+0.02B--%
EBITExceed expectations
0.39B--
0.34B--
+0.05B--%
EPSExceed expectations
0.1510.33%
0.1379.57%
+0.01409.24%

Upcoming earnings report - FY2027 Q2 Earning Release

Available dateNov 24, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly